West and North London Community Outreach, Prevention and Vaccination Service 2027/28 - Lot 2 - Barnet, Camden, Enfield, Haringey and Islington

Tender description

NHS England (London Region) (Commissioners) with support of West and North London Integrated Care Board is seeking to commission Lot 2 of the West and North London Community Outreach, Prevention and Vaccination Service for 1 April 2027 to 31 March 2028 with option to extend for a further 12 months to 31 March 2029.The service will provide a flexible, innovative and community-embedded outreach platform linking vaccination with prevention, Making Every Contact Count, supported navigation, neighbourhood working and trusted community partnerships. It will target provision gaps beyond routine primary care, community pharmacy and other commissioned routes, using evidence of unmet need, lower uptake, health inequalities, barriers to access, clinical risk and local intelligence. The annual contract value is £414,000 Lot 1: The Provider must be capable of delivering across Lot 2 of the commissioned West and North London footprint and responding to borough and neighbourhood priorities. Lot 2 comprises: Barnet, Camden, Enfield, Haringey and Islington. The service must maintain a rolling, data-led outreach plan and provide mobile, roving, pop-up, satellite, co-located and event-based delivery in trusted and accessible settings, including use of an outreach vehicle where appropriate. Delivery must include community engagement, authorised vaccination activity, prevention and Making Every Contact Count interventions, supported referral and signposting, partnership working and evaluation. Deployment must be targeted and proportionate, addressing geographic, socioeconomic, cultural, linguistic, digital and practical barriers. Priority populations include communities experiencing higher deprivation or poorer health outcomes; ethnic minority communities; people experiencing homelessness or insecure housing; refugees, asylum seekers and vulnerable migrants; Gypsy, Roma and Traveller communities; people with severe mental illness, learning disabilities, autism, long-term conditions or increased clinical risk; and groups affected by digital exclusion, low health literacy, mobility barriers, caring responsibilities or restrictive working patterns. Where vaccination is commissioned and activated, the Provider must comply with the national guidance, Commissioner instructions, legal mechanisms and clinical governance arrangements in force at the time. This includes eligibility and clinical suitability checks, informed consent, authorised and competent vaccinators, current Green Book and relevant national guidance, robust cold-chain and stock controls, prompt clinical recording, adverse-event management and coordination with other providers. The Provider must operate as an enabling partner to borough and neighbourhood arrangements. It must work with local authorities, public health, general practice, primary care networks, community pharmacies, acute, community and mental health providers, education, housing and homelessness services, faith and cultural organisations, employers, Healthwatch and VCS/VCSE organisations. Any approved subcontracting does not remove the lead Provider's accountability for quality, safety, performance, equitable coverage, data quality and reporting. The service must provide appropriate access routes, physically accessible and clinically safe venues, privacy and dignity, reasonable adjustments, non-digital alternatives, interpreting and accessible information. People must not be excluded solely because they lack an NHS number, digital access, proof of address or English fluency, unless a legal eligibility requirement applies. The Provider must maintain a competent workforce, named service and clinical leadership, appropriate training and supervision, integrated clinical and safeguarding governance, information governance, digital resilience, incident management, business continuity and reporting. Local reporting must cover outreach activity, contacts and interventions, vaccinations where applicable, MECC activity, inequalities, partner participation, experience, incidents, wastage, constraints, evaluation, cost and value. Unless separately commissioned in writing, the core service excludes routine care-home vaccination, routine housebound vaccination, long-term operation of a vaccination centre, replacement of the core responsibilities of other providers, uncommissioned clinical activity and ongoing management of diagnosed conditions or urgent care beyond immediate response and safe escalation. Additional information: The final 2027/28 NHS contractual schedules, national programme specifications, eligibility guidance, payment arrangements, reporting requirements, mandated systems and campaign dates will apply once published and may supersede this local requirement. The Provider must complete mobilisation before service commencement and maintain safe continuity during transition. Required deliverables include a mobilisation plan and risk register; named leadership, clinical governance and escalation arrangements; a borough and neighbourhood stakeholder map and operating model; relevant community pharmacy and VCS/VCSE partnership plans; a rolling outreach plan and deployment schedule; readiness assurance; accessible communications and engagement plans; a baseline, performance dashboard and evaluation framework; and regular contract, clinical and borough/neighbourhood reporting. Role and Responsibilities of the provider: The service provider's role is to lead and coordinate the service, and they will be responsible for: • lead and coordinate the service, with named operational leadership and a named registered clinical lead wherever clinical services are delivered; • use Commissioner data, population health intelligence, access analysis, borough insight and community knowledge to identify priority cohorts, locations and interventions; • maintain a rolling, evidence-led outreach plan linked to borough and neighbourhood priorities, with a recorded rationale for targeted activity; • deliver accessible mobile, roving, pop-up, satellite, event-based and co-located outreach and adapt delivery using rapid-cycle learning; • establish and maintain effective partnerships with neighbourhood teams, public health, local authorities, primary care, community pharmacy, VCS/VCSE organisations and other locally relevant partners; • ensure vaccination activity is authorised, clinically governed and delivered by appropriately trained, competent and authorised staff; • maintain workforce, safeguarding, medicines, infection prevention, information governance, clinical safety, incident, complaints, risk and business-continuity arrangements; • maintain safe premises, equipment, transport, storage, connectivity, cold-chain, stock, expiry, wastage and clinical-waste controls; • record activity promptly in mandated systems and provide complete, accurate and timely performance, quality, inequalities and evaluation reporting; • remain fully accountable for approved partners and subcontractors, including quality, safety, performance, equitable coverage, data quality and reporting; • support outbreak, surge and other time-limited priorities where formally requested and within the agreed contractual and financial arrangements; and • maintain an improvement log, share learning and demonstrate decisions to stop, adapt or scale activity according to evidence of impact. The ICB will be guided by the five key criteria outlined in the NHS Provider Selection Regime for evaluation of submissions in this process to select a suitable provider. These criteria are: 1. quality and innovation 2. value 3. integration, collaboration and service sustainability 4. improving access, reducing health inequalities and facilitating choice 5. social value